ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
462 hedge funds and large institutions have $25.3B invested in Alexion Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 167 increasing their positions, 169 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 437 → 462 (+25)
1% less repeat investments, than reductions
Existing positions increased: 167 | Existing positions reduced: 169
Holders
462
Holding in Top 10
8
Calls
$260M
Puts
$128M
Top Buyers
| 1 | +$231M | |
| 2 | +$199M | |
| 3 | +$142M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$84M |
| 5 |
Millennium Management
New York
|
+$66.7M |
Top Sellers
| 1 | -$169M | |
| 2 | -$127M | |
| 3 | -$84.7M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$76.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$75.8M |